行情

EBS

EBS

Emergent Bio
NYSE

实时行情|Nasdaq Last Sale

56.02
-2.09
-3.60%
盘后: 56.02 0 0.00% 16:00 01/24 EST
开盘
58.59
昨收
58.11
最高
58.59
最低
55.82
成交量
27.58万
成交额
--
52周最高
67.45
52周最低
39.11
市值
28.92亿
市盈率(TTM)
-3661.4379
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

EBS 新闻

  • B站向武汉捐赠1000万元专项资金及超30万元防护物资
  • IT之家.6小时前
  • 阿里采购医疗物资驰援武汉
  • 经济日报.8小时前
  • 利比亚石油出口遭打击 6天损失近2.566亿美元
  • 央视.8小时前
  • 俄总防疫师:向中国同行致敬
  • 央视.9小时前

更多

所属板块

制药
-1.84%
制药与医学研究
-2.00%

热门股票

名称
价格
涨跌幅

EBS 简况

Emergent BioSolutions Inc. is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. It focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats (PHTs). The PHTs operates through two categories: Chemical, Biological, Radiological and Nuclear, as well as explosive-related threats and emerging infectious diseases. It operates through four business units: Vaccines and Anti-infectives; Antibody Therapeutics; Devices, and Contract Manufacturing. Vaccines and Anti-infectives business unit consists of BioThrax, which is for the general use prophylaxis and post-exposure prophylaxis of anthrax disease. Devices business unit consists of marketed products, such as Reactive Skin Decontamination Lotion Kit (RSDL) and Trobigard (atropine sulfate, obidoxime chloride).
展开

Webull提供Emergent Biosolutions Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。